An Investigation of Ethanolic Propolis Extracts: Their Potential Inhibitor Properties Against ACE-II Receptors for COVID-19 Treatment by Molecular Docking Study

doi 10.14293/s2199-1006.1.sor-.pp5bwn4.v1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

ScienceOpen

Related search

Potential Inhibitor of COVID-19 Main Protease (Mpro) From Several Medicinal Plant Compounds by Molecular Docking Study

2020English

Identification of Compounds From Nigella Sativa as New Potential Inhibitors of 2019 Novel Coronasvirus (Covid-19): Molecular Docking Study

2020English

Therapeutic Potential for Tetracyclines in the Treatment of COVID-19

Pharmacotherapy
Pharmacology
2020English

Potential Harmful Effects of Discontinuing ACE-inhibitors and ARBs in COVID-19 Patients

eLife
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2020English

Multidrug Treatment With Nelfinavir and Cepharanthine Against COVID-19

2020English

Potential Neurological Symptoms of COVID-19

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2020English

Outbreak Investigation for COVID-19 in Northern Vietnam

The Lancet Infectious Diseases
Infectious Diseases
2020English

Synthesis of Diabetic II Inhibitors Based on 2-Mercaptobenzimidazole and Their Molecular Docking Study

2019English

Hypothesis: Advanced Biotechnological Treatment Approaches Against SARS-CoV-2 (COVID-19)

Volume 5 - 2020, Issue 4 - April
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy